The three-stage clinical trial design was found to be consistently superior to the traditional randomized trial design in all cases examined, with sample sizes typically reduced by 20 per cent to 30 per cent while maintaining comparable power. When a treatment clearly superior to placebo was ...
At least one clinical trial is looking into using Opdivo and Yervoy to treat peritoneal mesothelioma. Study patients must qualify for CRS combined with chemotherapy. Learn More About Immunotherapy for Mesothelioma Multimodal Therapy A multimodal approach is often used to treat stage 3 mesothelioma. Mult...
With its unique mRNA therapeutics platform, Arcturus Therapeutics is a leading clinical-stage mRNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases.
Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301) 2012, The Lancet Oncology more Shinji Atagi, Masaaki Kawahara, Akira Yokoyama, Hiroaki ...
Among the enrolled participants, 26 (55.3%) were classified as stage IIIA, 18 (38.3%) as stage IIIB, and 3 (6.4%) as stage IIIC. Fig. 1: The clinical trial (TEAM-LungMate 004) design and clinical efficacy. NE: non-evaluation; PD: progressive disease; PR: partial response; R0 ...
About KEYNOTE-671 KEYNOTE-671 is a randomized, double-blind Phase 3 trial (ClinicalTrials.gov, NCT03425643) evaluating neoadjuvant KEYTRUDA plus chemotherapy, followed by adjuvant KEYTRUDA as a single agent versus placebo plus neoadjuv...
This phase 3 randomized clinical trial investigates if the addition of ipilimumab to nivolumab improves the survival outcome of patients with
3 Recent data with immune checkpoint inhibitors targeting the programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) pathway, combined with platinum-based chemotherapy, have demonstrated improved clinical outcomes as first-line treatment of patients with extensive-stage (ES)-SCLC, ...
KEYNOTE-A18, also known as ENGOT-cx11/GOG-3047, is a multicenter, randomized, double-blind, placebo-controlled Phase 3 trial (ClinicalTrials.gov, NCT04221945) sponsored by Merck and conducted in collaboration with the European Network for Gynaecologi...
1.1 anti-liver cancer drug III domestic multi-center clinical trial of 300 subjects in 24 centers 翻译结果2复制译文编辑译文朗读译文返回顶部 正在翻译,请等待... 翻译结果3复制译文编辑译文朗读译文返回顶部 , 1.1 class anti-hepatocarcinoma stage ⅲ phase national multicenter clinical trial of new drug ...